Harmony Biosciences Holdings (HRMY) — Capital Reinvestment Ratio
Harmony Biosciences Holdings (HRMY) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($126.15 Million) in capital expenditures ($107.00K). Check HRMY intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Harmony Biosciences Holdings Capital Reinvestment Ratio (2021–2025)
This chart tracks Harmony Biosciences Holdings's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see Harmony Biosciences Holdings cash conversion from operations.
Annual Capital Reinvestment Ratio for Harmony Biosciences Holdings (2021–2025)
Year-by-year Capital Reinvestment Ratio for Harmony Biosciences Holdings from 2021 to 2025. See HRMY FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $348.20 Million | $310.00K | ▼ -83.0% |
| 2024 | 0.01x | $219.82 Million | $1.15 Million | ▲ +268.8% |
| 2023 | 0.00x | $219.39 Million | $312.00K | ▲ +19.4% |
| 2022 | 0.00x | $144.47 Million | $172.00K | ▼ -60.6% |
| 2021 | 0.00x | $98.56 Million | $298.00K | — |